THE ENDOSYMBIOTIC EVOLUTION: AN UNEXPLOITED BIOTECHNOLOGY
ENDOBIOS has been navigating the uncharted waters of the eukaryotic cytoplasm for 10+ years’, on a quest to find new biological features of endosymbiotic bacteria (see Almeida et al., 2018).
Our intellectual property encompasses paradigm-shifting discoveries of endobacterial symbiotic biology traits, which are being biotechnologically exploited by ENDOBIOS.
For us, endosymbioses are the new norm, influencing evolution, health and disease.
WHAT WE DO:
We are currently validating a paradigm shift in this field (more to follow).
If you are engaged in endosymbiont R&D projects, we can share our 10+ years’ of know-how (mostly unpublished) to increase your research focus, saving you time and resources.
Contact us for further information.